Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.
Journal: Nature medicine
Published: April 23, 2026
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.
Journal: Nature medicine
Published: July 29, 2025
Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy.
Journal: The Journal of clinical investigation
Published: March 28, 2025
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Journal: The Lancet. Neurology
Published: August 27, 2024
A Multimodal Intervention to Improve the Quality and Safety of Interhospital Care Transitions for Nontraumatic Intracerebral and Subarachnoid Hemorrhage.
Journal: Joint Commission journal on quality and patient safety
Published: February 20, 2020
Showing 1-6 of 6
Last Updated: 09/26/2026